ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,107.20
      -0.96%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.505
      -0.33%
      Bitcoin
      65,664.85
      -0.39%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Extendicare Inc (EXE) Quote

      Extendicare Inc

      Extendicare Inc (EXE)

      Exel Industries
      7.55
      0.05
      (0.67%)
      Closed July 23 4:12PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      7.55
      Bid
      7.51
      Ask
      7.57
      Volume
      73,766
      7.44 Day's Range 7.57
      5.75 52 Week Range 8.03
      Market Cap
      88.924M
      Previous Close
      7.50
      Open
      7.44
      Last Trade
      49
      @
      7.55
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      124,879
      Shares Outstanding
      11,778,000
      Dividend Yield
      -
      PE Ratio
      2.62
      Earnings Per Share (EPS)
      2.89
      Revenue
      1.3B
      Net Profit
      33.98M

      About Extendicare Inc

      Sector
      Nursng,personal Care Fac,nec
      Industry
      Real Estate Investment Trust
      Website
      www.extendicare.com
      Headquarters
      Markham, Ontario, Can
      Founded
      1993
      Extendicare Inc is listed in the Nursng,personal Care Fac sector of the Toronto Stock Exchange with ticker EXE. The last closing price for Extendicare was $7.50. Over the last year, Extendicare shares have traded in a share price range of $ 5.75 to $ 8.03.

      Extendicare currently has 11,778,000 shares outstanding. The market capitalization of Extendicare is $88.34 million. Extendicare has a price to earnings ratio (PE ratio) of 2.62.

      EXE Latest News

      More News

      Extendicare Announces July 2024 Dividend of C$0.04 per Share

      MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

      July 15 2024
      GlobeNewswire Inc.

      Extendicare Announces Timing of 2024 Second Quarter Results and Conference Call

      MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second...

      July 05 2024
      GlobeNewswire Inc.

      Extendicare Announces Renewal of Normal Course Issuer Bid

      MARKHAM, Ontario, June 26, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the...

      June 26 2024
      GlobeNewswire Inc.

      Extendicare Announces June 2024 Dividend of C$0.04 per Share

      MARKHAM, Ontario, June 17, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

      June 17 2024
      GlobeNewswire Inc.

      Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders

      MARKHAM, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of...

      May 23 2024
      GlobeNewswire Inc.

      Extendicare Announces 2024 First Quarter Results

      MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2024. Results are...

      May 15 2024
      GlobeNewswire Inc.

      Extendicare Announces April 2024 Dividend of C$0.04 per Share

      MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

      April 15 2024
      GlobeNewswire Inc.

      Extendicare Announces Timing of 2024 First Quarter Results and Conference Call

      MARKHAM, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first...

      April 04 2024
      GlobeNewswire Inc.

      Extendicare ouvre les marchés

      Extendicare ouvre les marchés Canada NewsWire TORONTO, le 15 févr. 2024 TORONTO, le 15 févr. 2024 /CNW/ - Le Dr Michael Guerriere, président et chef de la direction, Extendicare Inc. («...

      February 15 2024
      PR Newswire (Canada)

      Extendicare Opens the Market

      Extendicare Opens the Market Canada NewsWire TORONTO, Feb. 15, 2024 TORONTO, Feb. 15, 2024 /CNW/ - Dr. Michael Guerriere, President and Chief Executive Officer, Extendicare Inc...

      February 15 2024
      PR Newswire (Canada)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.263.566529492467.297.577.21676847.40203623CS
      40.243.283173734617.317.577.1757737.28501605CS
      120.293.994490358137.268.037.11248797.5097311CS
      260.385.299860529997.178.036.631256927.36040179CS
      520.152.027027027037.48.035.751280846.98682819CS
      156-1.03-12.00466200478.588.585.751578597.11852486CS
      260-1.07-12.41299303948.629.64.92135246.89135851CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
       20.10
      (839.25%)
      		128.82k
      RGCRegencell Bioscience Holdings Ltd
      $ 15.15
      (349.55%)
      		1.34M
      ATPCAgape ATP Corporation
      $ 0.2262
      (58.18%)
      		107.31M
      SLRXSalarius Pharmaceuticals Inc
      $ 2.34
      (51.95%)
      		60.04M
      GSUNGolden Sun Health Technology Group Ltd
      $ 7.46
      (45.42%)
      		589.98k
      FLYEFly E Group Inc
      $ 1.1601
      (-81.82%)
      		25.44M
      RNAZTransCode Therapeutics Inc
      $ 0.3035
      (-61.70%)
      		9.78M
      JAGXJaguar Health Inc
      $ 1.755
      (-58.90%)
      		15.47M
      MIRAMIRA Pharmaceuticals Inc
      $ 2.55
      (-49.10%)
      		25.64M
      IVPInspire Veterinary Partners Inc
      $ 5.19
      (-43.83%)
      		1.67M
      SLNASelina Hospitality PLC
      $ 0.026
      (-29.73%)
      		220.18M
      SPWRSunPower Corporation
      $ 0.9514
      (32.91%)
      		186.75M
      NVDANVIDIA Corporation
      $ 122.59
      (-0.77%)
      		173.87M
      ADILAdial Pharmaceuticals Inc
      $ 1.3422
      (26.62%)
      		160.04M
      HOLOMicroCloud Hologram Inc
      $ 0.588
      (26.07%)
      		135.53M

      EXE Discussion

      View Posts
      MisterEC MisterEC 9 years ago
      I have traded this a number of times. Back in at 5.90 this morning. Below is a statement from the Motley Fool analyst I heard about this stock from. Unfortunate I lost track of his coverage and all my trades were done after this was released, and before I read this, except when I got back in today.

      Extendicare (NASDAQOTH:EXETF) -- This was a truly unfortunate experience, as management just worked over
      shareholders in a terrible way. It ran the REIT's American business into the ground and then sold it at a low point
      (very much like buy high/sell low investors). The conference call announcing the deal was unbelievable, and you
      could hear the anxiety in the CEO's voice as he delivered the news and parried questions from analysts. With only
      a little cash going back to shareholders in the form of a stock buyback -- surely after some investors twisted
      management's arm -- shareholders were right to dump the stock. It would be much more accretive to buy back stock
      at these prices, but management wants to expand the business. That would be poor capital allocation.
      James Royal
      (TMFRoyal)
      Jan 23, 2015 at 10:06AM
      👍️0
      clotter2 clotter2 9 years ago
      Extendicare breaking resistance level. This should get good from here . LONG+
      👍️0
      clotter2 clotter2 9 years ago
      I want to talk $EXETF $TROV.. Health-care, Biopharm, and retail...
      👍️0
      toddski toddski 9 years ago
      Extendicare (TSE:EXE) had its price target upped by CIBC from C$7.50 to C$8.00 in a research note issued to investors on Friday. The firm currently has a sector perform rating on the stock.

      http://www.mideasttime.com/extendicare-given-new-c8-00-price-target-at-cibc-exe/362393/
      👍️0
      toddski toddski 10 years ago
      Extendicare announced 10% share buyback program:

      http://finance.yahoo.com/news/extendicare-announces-intention-issue-normal-223000319.html
      👍️0

      Your Recent History

      TSX
      EXE
      Extendicare
      TSXV
      PML
      Panoro Minerals
      TSXV
      UHO
      United Hunter Oil and Gas
      Delayed Upgrade Clock